JPRN-jRCT1080222824
Unknown
Phase 4
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain
ConditionsDiabetic Peripheral Neuropathic Pain
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Sponsor
- Shionogi & Co., Ltd.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants present with pain due to bilateral, peripheral neuropathy.
Exclusion Criteria
- •Participants who have hypersensitivity to multiple medications.
- •Participants who have undergone renal transplant, or are currently undergoing renal dialysis.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
the effect of duloxetine on theanxiety and depression of patients with diabetic neuropathyCondition 1: Effect of Duloxetine on the Mental State of Patients (Anxiety) with Diabetic Neuropathy. Condition 2: Effect of Duloxetine on the Mental State of Patients (Depression) with Diabetic Neuropathy.Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathyE08.43IRCT20210725051977N2Islamic Azad University30
Unknown
Phase 3
A Phase III Clinical Trial of Duloxetine in Participants With FibromyalgiaFibromyalgiaJPRN-jRCT2080221737SHIONOGI & CO., LTD.
Completed
Not Applicable
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with RitaliIRCT201110127462N2Tehran University of Medical Sciences40
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with osteoarthritisJPRN-jRCT2080222625Shionogi & Co., Ltd.
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with chronic low back paiChronic low back painJPRN-jRCT2080222083SHIONOGI & CO., LTD.